Physician

Ainah Uy Tan, M.D.

According to 2025 Medicare claims, Ainah Tan, M.D. (NPI: 1215371810) practices dermatology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is DUPAGE MEDICAL GROUP LTD (NPI: 1801833983; TIN: 36-2657618) and primary practice location at 60137-4464. Tan is affiliated with the DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (ACO ID: D0265), participating under the REACH model.

Tan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 714 traditional Medicare patients, billed 2,227 HCPCS/CPT codes, and received $124,658 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 892 prescription claims across 363 beneficiaries totaling $352,589 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 11 records totaling $321. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $36,132 to $124,658. Similarly, Part D prescription costs have moved sharply higher in recent years, from $11,655 to $352,589. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$65K$130K2017 Medicare payment: $36,132 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $103,692 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $107,737 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $116,495 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $68,251 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $117,534 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $129,915 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $124,658 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017196664$36,132
20185202,282$103,692
20195632,099$107,737
20205542,008$116,495
20214271,230$68,251
20226561,964$117,534
20236872,215$129,915
20247142,227$124,658

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$176K$353K2017 Drug cost: $11,655 (USD; Tot_Drug_Cst)2018 Drug cost: $108,215 (USD; Tot_Drug_Cst)2019 Drug cost: $129,581 (USD; Tot_Drug_Cst)2020 Drug cost: $179,574 (USD; Tot_Drug_Cst)2021 Drug cost: $269,422 (USD; Tot_Drug_Cst)2022 Drug cost: $226,777 (USD; Tot_Drug_Cst)2023 Drug cost: $273,618 (USD; Tot_Drug_Cst)2024 Drug cost: $352,589 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
201781175$11,655
2018287756$108,215
2019317908$129,581
20203501,121$179,574
2021283763$269,422
2022315726$226,777
2023339900$273,618
2024363892$352,589

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more143204$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more414539$58
17000Destruction of precancer skin growth, 1 growth122147$43
88305Pathology examination of tissue using a microscope, intermediate complexity155332$26
17003Destruction of precancer skin growth, 2-14 growths85387$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11868$226,021
Dupixent PenDupilumab13364$50,925
Clobetasol PropionateClobetasol Propionate1484,568$6,126
TacrolimusTacrolimus23595$3,145
MetronidazoleMetronidazole411,106$2,223

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$321Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ainah Uy Tan, M.D.?

Tedicare shows public-source Medicare data for Ainah Uy Tan, M.D. (NPI 1215371810), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ainah Uy Tan, M.D. have ACO affiliation data?

Ainah Uy Tan, M.D. is shown with ACO affiliation data for DULY HEALTH AND CARE ACCOUNTABLE CARE ORGANIZATION (REACH, ACO ID D0265).

What billing organization is linked to Ainah Uy Tan, M.D.?

Ainah Uy Tan, M.D. is linked to DUPAGE MEDICAL GROUP LTD (billing NPI 1801833983) in the available physician profile data.

Does Ainah Uy Tan, M.D. have Open Payments data?

Ainah Uy Tan, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.